ArticleClinical interventions in aging2026
Associations of Inflammatory Biomarkers with Disease Severity in Elderly Patients with Sepsis-Associated ARDS: A Cross-Sectional Study.
Article in Clinical interventions in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis-associated acute respiratory distress syndrome (ARDS) is associated with high mortality, particularly in elderly patients. Reliable biomarkers for early severity stratification remain limited. Objective: To evaluate the associations of four inflammatory biomarkers-endothelial cell-specific molecule-1 (ESM-1), soluble urokinase plasminogen activator receptor (suPAR), procalcitonin (PCT), and heparin-binding protein (HBP)-with disease severity in elderly patients with sepsis-associated ARDS. Methods: This cross-sectional study included 168 elderly patients (≥60 years) with sepsis-associated ARDS. Serum levels of ESM-1, suPAR, PCT, and HBP were measured at enrollment. Disease severity was assessed using the APACHE II, SOFA, and MLIS scores, and the PaO Results: All four biomarkers increased stepwise across the mild, moderate, and severe ARDS groups (all P < 0.001). ESM-1 showed the strongest correlation with ARDS severity ( Conclusion: ESM-1, PCT, and HBP are independently associated with disease severity in elderly patients with sepsis-associated ARDS. ESM-1 demonstrated discriminative ability comparable to conventional severity scores and may serve as an adjunctive marker for severity assessment at enrollment, pending prospective validation. Limitations include the single-center, cross-sectional design and the lack of external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.